AMAlain Moga

Alain Moga

*This is an algorithmically generated author record based on publicly available information.

Alain Moga has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ESDR207 - An innovative preclinical mouse model of atopic dermatitis

    by Cecile Bize, Christophe Fremez, Ambre De Pooter, Guillaume Lecerf, Alain Moga, Maxime Fontanié, Patricia Martin

    Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by highly pruritic inflamed skin lesions and dry skin. AD affects up | POSTER

  • ESDR539 - Positive contribution of active molecules combined with sun filters evaluated by in vivo biomarkers analysis

    by Arnaud Fontbonne, Elise Abric, Alain Moga, Sylvie Callejon, Félix Giraud, Cécile Garin, Nathalie Ardiet, Benoit Cadars, Aurélie Guyoux, Sandra Trompezinski

    Skin photoprotection has become a real public health issue. The major role of UVA rays has long been neglected, even though their harmful effect | POSTER

  • Open Access

    Clinical Evaluation of Indian Sandalwood Oil and Its Protective Effect on the Skin against the Detrimental Effect of Exposome

    by Vimi Lutchmanen Kolanthan, Andrew Brown, Vitisha Soobramaney, Evans Georges Philibert, Veronique Francois Newton, Muzzammil Hosenally, Bibi Nusayha Sokeechand, Gitanjali Petkar, Alain Moga, Philippe Andres, et al.

    The skin is constantly subject to external stressors (the exposome), including particulate matter and blue light. These can penetrate the deeper layers of the skin, inducing the release of free radicals and triggering an inflammatory cascade of events contributing to cutaneous aging and exacerbating inflammatory skin conditions. This study demonstrates the clinical efficacy of Indian sandalwood oil of varying concentrations against oxidative stress induced by urban dust and blue light. Twenty-two healthy human subjects entered and completed the study of 11 days. Test products containing 0.1%, 1% and 10% of sandalwood oil, as well as a placebo and a comparator control (α-tocopherol), were applied on the different investigational zones of the upper back of each subject. Exposure ensued on day 7, using a controlled pollution exposure system (CPES) and blue light at a wavelength of 412 nm. Sebum was sampled on each investigational zone following the last exposure. The level of squalene monohydroperoxide (SQOOH) was the primary endpoint. A dose-dependent decrease in SQOOH on the zones treated with 10%, 1% and 0.1% of the sandalwood oil formulation compared to the untreated zones was observed. The zone treated with the 10% sandalwood-containing formula demonstrated the highest protective efficacy with the lowest amount of SQOOH. Increasing the concentration of the sandalwood oil increased its protective antioxidant activity. The results collected from this intraindividual comparative is the first clinical trial to suggest that sandalwood oil at a concentration between 1% and 10% protects the skin against the oxidative stress induced by urban dust and blue light exposure.